Karyopharm Therapeutics, Inc. (KPTI)
8.82
-0.33
(-3.61%)
USD |
NASDAQ |
Mar 05, 16:00
8.77
-0.05
(-0.57%)
After-Hours: 20:00
Karyopharm Therapeutics Cash from Investing (Quarterly) : 5.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -37.17M |
| Baxter International, Inc. | -198.00M |
| Bruker Corp. | -55.50M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| Agios Pharmaceuticals, Inc. | 90.08M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.83M |
| Cash from Financing (Quarterly) | 29.69M |
| Free Cash Flow | -75.37M |
| Free Cash Flow Per Share (Quarterly) | -0.6606 |
| Free Cash Flow to Equity (Quarterly) | -49.01M |
| Free Cash Flow to Firm (Quarterly) | 0.7827M |
| Free Cash Flow Yield | -78.28% |